Nova Biomedical CONTROL BIOPROFILE LEVEL 2 22601
Nova Biomedical -- Item TECPIM000412265
Please add to cart & request for quote to see the price
Reserve Now
Nova Biomedical CONTROL BIOPROFILE LEVEL 2 22601 is a quality control material used for validating the performance of Nova Biomedical's Bioprofile Analyzers, ensuring accurate and reliable results in laboratory testing.
Benefits/Advantages:
- Reliable Quality Control: Ensures the accuracy and precision of test results.
- Consistent Performance Monitoring: Facilitates ongoing monitoring of analyzer performance.
- Ease of Use: Simple and convenient control material for routine testing.
Product Details
Overview
| Model | |
|---|---|
| Product Type | Consumables |
| Part Number | 22601 |
| Brand | Nova Biomedical |
| Gross Dimensions (WxDxH cm) | |
| Net Dimensions (WxDxH cm) | |
| Gross Weight (kg) | |
| Net Weight (kg) |
Specifications
More options are available. Please contact us for more information.
Document
More options are available. Please contact us for more information.
Videos
Nova Biomedical
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers.
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
With manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan, Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.